
A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma. A patented computer-aided diagnostic system developed by Lithuanian scientists proved to be more than 90% accurate in detecting malignancy in diagnostic images of skin lesions acquired from 100 patients.
In Europe, melanoma is the fifth most common type of cancer and is the major cause of death from skin cancer. Northern Europe displays the largest age-standardised rate mortality of 3.8 per 10,000 in the region, with an incidence of 23.4.
Excision of a primary tumour remains essential in diagnosing melanoma, and the decision for the operation is generally based on the dermatoscopic evaluation of the lesion. However, the accuracy of melanoma clinical diagnosis is only at 65% and strongly relies on the experience of the physician-dermatologist carrying out the analysis.
“The novelty of our method is that it combines diagnostic information obtained from different non-invasive imaging technologies such as optical spectrophotometry and ultrasound. Based on the results of our research, we can confirm that the developed automated system can complement the non-invasive diagnostic methods currently applied in the medical practice by efficiently differentiating melanoma from a melanocytic mole”, says Professor Renaldas Raišutis, head of the team behind the research at Kaunas University of Technology.
In the study, carried out by the researchers of two Lithuanian universities, diagnostic images of skin lesions acquired from 100 different patients were evaluated. By comparing and analysing complex data on skin tumours recorded by different techniques, the researchers were able to develop a novel diagnostic system, differentiating melanoma from a benign nevus with accuracy higher than 90%.
“An efficient diagnosis of an early-stage malignant skin tumour could save critical time: more patients could be examined and more of them could be saved”, says Prof Raišutis.
According to Prof Raišutis, the novel diagnostic system is firstly aimed at medical professionals; he estimates that the price of the final product might be affordable even for smaller medical institutions. However, the team is also thinking about the solutions for individual use at home.
Following the research, the prototype of the technology was developed, and the clinical research is being carried out complying with the requirements of the protocol for the clinical research confirmed by the regional bioethics committee.
The invention was patented in Lithuania (Patent No. LT6670B) and the patent applications filed for Patent Cooperation Treaty and the United States Patent and Trademark Office.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Melanoma detection
- Colorectal cancer is rising among young adults; scientists don't know why
but deeper analysis shows you that part of that is due to earlier detection and more screening," he said. "So that could be one facet of the equation." Overall, pinpointing what could be driving this ...
- Dermatology Devices Global Market Report 2023: Increasing Prevalence of Skin Cancer and Other Conditions Fuels Demand
The 3DermSpot is an algorithm designed to use artificial intelligence (AI) and highly standardized skin images to help in autonomously detecting melanoma, squamous cell carcinoma, and basal cell ...
- Your Health: What to know about colorectal cancer screening
Regarding colorectal cancer, perhaps the most effective way to remain healthy is to stay in the know with one simple but powerful solution: screening. Several low-risk procedures can ensure early ...
- Colorectal cancer is rising among younger adults and scientists are racing to uncover why
but deeper analysis shows you that part of that is due to earlier detection and more screening,” he said. “So that could be one facet of the equation.” Overall, pinpointing what could be driving this ...
- Owlstone Medical and Bicycle Therapeutics’ new research partnership to begin with focus on lung cancer diagnosis
Owlstone Medical and Bicycle Therapeutics’ new research agreement will explore the potential of combining technologies and methods to develop antigen-targeted diagnostic probes that use bicyclic ...
Go deeper with Google Headlines on:
Melanoma detection
[google_news title=”” keyword=”melanoma detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Melanoma
- Melanoma Market SWOT Analysis till 2030
The Global Melanoma market is expected to progress at a substantial rate during the forecast period, between 2023 and 2029. In 2023, the market is rising at a stable rate and with the increasing ...
- New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in Cancer showing the prognostic and predictive utility of Natera’s personalized and ...
- Global Acral Lentiginous Melanoma Drugs Market to Grow from 2023-2026
Mar 22, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The Global Acral Lentiginous ...
- Advanced surgical therapy proves to be effective for patients with uveal melanoma liver metastases
An advanced surgical therapy has proved considerably more efficacious than conventional treatments for patients with melanoma in the eye (uveal) that has spread to the liver, a University of ...
- Kat Dunell organises Geelong Melanoma March
A Newtown mum is on a sun smart mission, triggered by the tragedy of losing her husband after he was diagnosed with melanoma.
Go deeper with Google Headlines on:
Melanoma
[google_news title=”” keyword=”melanoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]